Vice President, Late Stage Ophthalmology - DME

4D Molecular Therapeutics(6 days ago)

Emeryville, CaliforniaOnsiteFull TimeExecutive$350,000 - $440,000Drug Development

About this role

The VP, Late Stage Ophthalmology at 4DMT is a senior physician leadership role within Drug Development focused on advancing late-stage ophthalmic genetic medicine programs. The role is part of the executive medical leadership reporting to the Chief Medical Officer and supports the company’s retinal and ocular therapeutic candidates as they progress toward regulatory submission and approval.

View Original Listing

Required Skills

Medical Monitoring
Clinical Trials
Protocol Development
Regulatory Submissions
Pharmacovigilance
Clinical Operations
Biostatistics
Team Leadership
Strategic Planning
Data Interpretation

+4 more

Qualifications

M.D. Degree
Clinical Training in Ophthalmology
Retina Fellowship (Preferred)
Board Certification

About 4D Molecular Therapeutics

4dmoleculartherapeutics.com

4D Molecular Therapeutics (4DMT) is a clinical-stage biotechnology company that designs, develops, and commercializes gene therapies for serious, unmet medical conditions. Using a proprietary AAV capsid engineering and targeted delivery platform, 4DMT creates vectors optimized for tissue specificity, potency, and manufacturability to improve safety and therapeutic benefit. The company focuses on translational programs across ocular, neuromuscular, central nervous system, and cardiopulmonary indications and partners to advance candidates toward clinical and commercial development.